Retraction Note: Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient? (Intensive Care Medicine, (1996), 22, 7, (644-650), 10.1007/BF01709740);Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient?

Intensive Care Medicine

Volumn 22, Issue 7, 1996, Pages 644-650

  Boldt, J ^a   Muller M ^b   Heesen, M ^b   Heyn, S ^b   Hempelmann, G ^b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Adenosine diphosphate; Aggregometry; Coagulation; Collagen; Critically ill; Epinephrine; Inflammation; Pentoxifylline; Platelet function; Sepsis; Trauma

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; CYTOKINE; FIBRINOGEN; INTERLEUKIN 1; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR;

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; INFLAMMATION; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TURBIDIMETRY; UNIVERSITY HOSPITAL;

EID: 0030056562     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-023-07129-1     Document Type: Erratum

References (26)

1. Bick RL (1992) Platelet function defects: a clinical review. Sem Thromb Hemost 18:167-185
2. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 101: 816-823
3. Hines R (1989) Infusion of sodium nitroprusside induces platelet dysfunction in vitro. Anesthesiology 70: 611-615
4. Weiss HJ (1982) Antiplatelet drugs: pharmacological aspects. In: Weiss HJ (ed) Platelets: pathophysiology and antiplatelet drug therapy. Liss, New York, pp 45-58
5. Campbell FW, Addonizio VP Jr (1988) Platelet function alterations during cardiac surgery. In: Ellison N, Jobes DR (eds) Effective hemostasis in cardiac surgery. Saunders, Philadelphia, pp 85-109
6. Suffredini AF (1994) Current prospects for the treatment of clinical sepsis. Crit Care Med 22:S12-S18
7. Schade UF (1990) Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock 31: 171-181
8. Coccia MT, Waxman K, Soliman MH, Tominaga G, Pindereski L (1989) Pentoxifylline improves survival following hemorrhagic shock. Crit Care Med 17:36-38
9. Sato K, Stelzner TJ, O'Brien RF, Weil JV, Welsh CH (1991) Pentoxifylline lessens the endotoxin-induced increase in albumin clearance across pulmonary artery endothelial monolayers with and without neutrophils. Am J Respir Cell Mol Biol 4:219-227
10. Sullivan GW, Carper HT, Novick WJ, Mandell GL (1988) Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 56:1722-1729
11. Josaki K, Contrino J, Kristie J, Krause P, Kreutzer DL (1990) Pentoxifylline-induced modulation of human leukocyte function in vitro. Am J Pathol 136:623-630
12. Ward A, Clissold SP (1987) Pentoxifylline - a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34:50-97
13. Lapetina EG, Schitges A, Chandrabose K (1977) Cyclic adenosine 3′5′-monophosphatase and prostacyclin inhibit membrane phospholipase activity in platelets. Biochem Biophys Res Commun 14:39-50
14. Kaser-Glanzmann R, Jakabova M, George JN, Luscher EF (1977) Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′5′-monophosphate and protein kinase. Biochim Biophys Acta 466:429-440
15. Baker SP, O'Neill B (1976) The injury severity score: an update. J Trauma 16:882-888
16. Members of the American College of Chest Physicians/Society of Critical Care Medicine Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
17. Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929
18. Bone RC (1992) Sepsis and coagulation. An important link. Chest 101: 594-595
19. Weithmann KU (1983) Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP. Gen Pharmacol 14:161-162
20. Hammerschmidt DE, Vercellotti GM (1987) Mechanism of action of pentoxifylline (PTX) in peripheral vascular disease: inhibition of platelet and granulocyte responsiveness. Clin Hemorheol 7:529-533
21. Schönharting M, Musikic P, Müller R (1988) The hemorheological and antithrombotic potential of pentoxifylline (Trental). Pharmatherapeutica 5: 159-169
22. Levi M, ten Cate, Bauer KA, van der Poll, Edgington TS, Buller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD (1994) Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 93: 114-120
23. Gordon JL (1985) Endothelium as a modulator of platelet reactivity. Adv Exp Med Biol 192:419-425
24. Noel P, Nelson S, Bokulic R (1989) Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Am Rev Resp Dis 139:A222
25. Lechner AJ, Rouben LR, Potthoff LH, Tredway TL, Matuschak GM (1993) Effects of pentoxifylline on tumor necrosis production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Circ Shock 39:306-315
26. Toung T, Kirsch J, Maruki Y, Traystman RJ (1994) Effects of pentoxifylline on cerebral blood flow, metabolism, and evoked response after total cerebral ischemia in dogs. Crit Care Med 22: 273-281